Related Experiment Video
Updated: Jul 3, 2026
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Pediatric patients with congenital heart disease: thrombin generation measured by calibrated automated thrombography
Andrea Rosenkranz1, Martin Koestenberger, Michael Novak
1Department of Pediatrics, Austria cInstitute of Physiological Chemistry, Centre of Physiological Medicine, Medical University Graz, Graz, Austria. Andrea.Rosenkranz@klinikum-graz.at
Insights
Calibrated automated thrombography offers a more accurate assessment of thrombin generation in pediatric congenital heart disease patients. This method provides a better reflection of coagulation status than standard assays like activated partial thromboplastin time.
Area of Science:
- Hematology
- Pediatric Cardiology
Background:
- Congenital heart disease (CHD) can significantly impact coagulation.
- Standard coagulation assays may not fully capture the complex hemostatic changes in these patients.
Purpose of the Study:
- To evaluate the utility of calibrated automated thrombography (CAT) for assessing coagulation in pediatric patients with CHD.
- To compare CAT-derived thrombin generation parameters with traditional coagulation tests.
Main Methods:
- CAT was used to measure thrombin generation in 60 pediatric CHD patients.
- Coagulation parameters including prothrombin, antithrombin, tissue factor pathway inhibitor, prothrombin fragment 1.2 (F1.2), and activated partial thromboplastin time (aPTT) were measured.
- Correlations between CAT results and standard parameters were analyzed.
Main Results:
- Significant positive correlations were found between prothrombin and endogenous thrombin potential (r = 0.295) and peak height (r = 0.581).
- Significant negative correlations were observed between tissue factor pathway inhibitor and endogenous thrombin potential (r = -0.480) and peak height (r = -0.234).
- No significant correlations were found between antithrombin and thrombin generation, or between aPTT and F1.2 or prothrombin.
Conclusions:
- CAT provides a more accurate determination of thrombin generation compared to standard global coagulation assays.
- CAT offers a superior method for reflecting the coagulation status in pediatric patients with congenital heart disease.
Abstract:
The aim of this study was to investigate the possible suitability of the calibrated automated thrombography to determine the coagulation status of pediatric patients with congenital heart disease. Thrombin generation was measured in 60 patients with congenital heart disease using the calibrated automated thrombography and compared to data using standard coagulation parameters such as prothrombin, antithrombin, tissue factor pathway inhibitor, prothrombin fragment 1.2 (F 1.2), and activated partial thromboplastin time. A significant positive correlation was observed between prothrombin and the endogenous thrombin potential (P < 0.01; r = 0.295) as well as between prothrombin and peak height (P < 0.01; r = 0.581). A significant negative correlation was seen between tissue factor pathway inhibitor and endogenous thrombin potential (P < 0.01; r = -0.480) and between tissue factor pathway inhibitor and peak height (P < 0.01; r = -0.234). No statistically significant correlation was found between antithrombin and parameters of continuous thrombin generation. Significant correlation was seen neither between activated partial thromboplastin time and F1.2 nor between activated partial thromboplastin time and prothrombin. The data presented here indicate that calibrated automated thrombography measurements determine thrombin generation more accurately and therefore reflect better the coagulation status of pediatric patients with congenital heart disease then standard global coagulation assays such as activated partial thromboplastin time.
